Formulation and optimization of liquisolid tablet for improving the dissolution profile of rivaroxaban by using DoE approachand antithrombic activity. Journal of Carcinogenesis, [S. l.], v. 24, n. 3s, p. 812–830, 2025. DOI: 10.64149/J.Carcinog.24.3s.812-830. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/1715. Acesso em: 17 dec. 2025.